儿童急性淋巴细胞白血病化疗期间感染及脓毒症的临床诊治分析

Clinical analysis in infection and sepsis during chemotherapy in children with acute lymphoblastic leukemia

  • 摘要: 目的 分析儿童急性淋巴细胞白血病(acute lymphoblastic leukemia,ALL)化疗期间感染及脓毒症的发生率及治疗情况,为感染防治提供参考。方法 对西南医科大学附属医院儿科血液病房2015年1月-2018年1月接受化疗的51例ALL患儿化疗期间发生感染及脓毒症的临床资料、危险因素、治疗与疗效进行回顾性分析。结果 51例患儿初诊年龄为1~13(6.96±3.34)岁,男24例,女27例。464例次化疗总感染率为40.5%(188/464),其脓毒症的发生率为14.2%(66/464),且好发于高危化疗组19.1%(31/162)和诱导缓解治疗阶段(22.64%)。49例次血培养阳性率20.4%(10/49)。脓毒症的原发感染部位以肺部为主,占24.2%(16/66)。中性粒细胞缺乏时间是ALL患儿脓毒症感染的独立危险因素,血培养中G-菌的检出率较高,应用碳青霉烯类抗生素治疗可相对有效地提高脓毒症治愈率。结论 脓毒症感染好发于高危化疗组和诱导缓解治疗阶段,肺部感染为最常见的原发感染。

     

    Abstract: Objective To analyze the incidence and treatment of infection and sepsis during chemotherapy in children with acute lymphoblastic leukemia(ALL) and provide evidences for prevention and treatment of infection. Methods Medical data of 51 children with ALL who received chemotherapy from January 2015 to January 2018 in pediatrics hematology ward of the affiliated Hospital of Southwest Medical University were retrospectively analyzed. Results There were 24 males and 27 females, with first diagnosis age of 1-13(6.96±3.34) years old. The total infection rate was 40.5%(188/464) when taking the number of chemotherapy courses into account; the incidence of sepsis was 14.2%(66/464), and it mostly occurred in high-risk chemotherapy group(19.1%, 31/162) and at the stage of induced remission(22.64%). The positive rate of blood culture in 49 cases was 20.4%(10/49). The primary infection site of sepsis was mainly in lung(24.2%, 16/66). Neutropenia duration was an independent risk factor for sepsis in children with ALL. The detection rate of G-bacteria in blood culture was high, while the use of carbapenem antibiotics could improve the cure rate of sepsis. Conclusion Sepsis mostly occurs in high-risk chemotherapy group and at the induced remission stage, and the lung is the most common site of primary infection.

     

/

返回文章
返回